sábado, 14 de noviembre de 2026
BuscarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 17, 2026

S&P 500 and Nasdaq 100 Soar to Record Highs as Middle East Tensions Ease

View original at nasdaq.com
S&P 500 and Nasdaq 100 Soar to Record Highs as Middle East Tensions Ease The S&P 500 Index ($SPX) (SPY) today is up +1.28%, the Dow Jones Industrial Average ($DOWI) (DIA) is up +2.07%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.326%…
Opening lines of the source · short snapshot — read the full document at the original

Lo que extrajimos de esta fuente

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Risks to the price outlook are tilted to the upside, especially in the near term, while the medium-term implications will depend on the intensity and duration of the war

    60% confidence
  • Iran made key concessions in an ongoing negotiation to end the seven-week war

    60% confidence
  • Q1 S&P 500 earnings projected to climb +12% y/y, and stripping out the technology sector, Q1 earnings are projected to increase around +3%, the weakest in two years

    60% confidence
  • The US and Iran are negotiating over a plan to end the war, with one element under discussion being that the US would release $20 billion in frozen Iranian assets in return for Iran giving up its stockpile of enriched uranium

    60% confidence
  • The US naval blockade in the Strait of Hormuz will remain in full force until a deal is fully agreed

    60% confidence
  • President Trump might travel to Pakistan if a deal with Iran is clinched

    60% confidence
  • The ECB needs to stay vigilant to potential inflation risks from the Iran war, but there is no obvious case to raise rates

    60% confidence
  • June is a better moment than April to decide whether an ECB interest rate response to the Iran war is necessary

    60% confidence

Data points we hold from this source

Exxon Mobil Corporation · stock return-6 percent

Citado en estos reportajes de Via News

Lo que sabemos · la inteligencia detrás de esta página
En vivo desde el sustrato
Lo que estamos viendo
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Nuestra lectura de los datos ›
Señales que seguimos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patrones que observamos ›
Donde las fuentes discrepan
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Señalamos los conflictos abiertamente ›
Verificado recientemente
✓ Verificado con la fuente original
4,995
hechos rastreados a su fuente — y señalamos los que no se sostienen.
101 entidades seguidas4,995 hechos verificados con la fuente5,577 documentos fuente archivados
Consulta estos datos → isubstrate.com